Masaki Kimura M.D., Ph.D.  木村将貴





  • 男性不妊症
  • 性機能障害
  • 男性更年期
  • マイクロサージャリー
  • 前立腺疾患



2002年 弘前大学医学部医学科卒業

2002年 横浜労災病院スーパーローテート研修医

2004年 北里大学病院 泌尿器科 入局

2005年 北里研究所病院 泌尿器科 医員

2008年 デューク大学泌尿器外科 Postdoctoral Fellow

2010年 コーネル大学Microsurgery Training and Research Program 修了

2012年 メリーランド大学ボルチモア校Radiation Oncology Research Associate

2013年 東邦大学大森病院リプロダクションセンター 客員講師

2014年 帝京大学医学部泌尿器科 講師



日本泌尿器科学会(泌尿器科専門医)、日本性機能学会(性機能学会専門医・評議員)、日本生殖医学会(生殖医療専門医)、日本アンドロロジー学会(評議員)、国際性機能学会、日本受精着床学会、日本性科学会、日本Men’s health医学会、日本抗加齢医学会



2006年 第94回 日本泌尿器科学会 総会賞 受賞

2010年 Josiah Charles Trent Memorial Foundation: Human sexual function grant 受賞

2011年 北米性機能学会Best of Top 10 Basic Science Papers受賞

2015年度 ~ 2017年度 日本学術振興会 科学研究費助成事業若手B研究 「2型糖尿病ラットモデルの勃起機能障害に対する有酸素運動の影響に関する研究」

2015年 GSKジャパン研究助成






  • Rank: Assistant Professor, Department of Urology, Teikyo University, Tokyo, Japan
  • Training: Hirosaki University School of Medicine, Hirosaki, Aomori, Japan, 2002
  • Residency: Kitasato University, School of Medicine, Sagamihara, Kanagawa, Japan, 2004-2008
  • Fellowship: Duke University Medical Center, Durham, NC, USA, 2008-2011
  • Current position: Assistant prof, Department of Urology, Teikyo University, Tokyo


Specialty and Research Interest

General andrology, prostate disease, male infertility, sexual/erectile dysfunction, late onset male hypogonadism, reconstruction surgery, priapism, surgery for Peyronie’s disease, no scalpel vasectomy





[1]Kimura M, Nagao K, Tai T, et al. Age is a significant predictor of early and late improvement in semen parameters after microsurgical varicocele repair. Andrologia. 2017 Apr;49(3).

[2]Kimura M, Zodda AR, Mahmood J, et al. Pilot Study Evaluating a Rat Model of Radiation-induced Erectile Dysfunction Using an Image-guided Microirradiator. Urology. 2015;85: 1214 e1-6.

[3]Kimura M, Muto S, Horie S. Opportunities for targeted focal treatment in Japan. Curr Opin Urol. 2015;25: 225-9.

[4]Kimura M, Nagao K. Role of varicocele repair for male infertility in the era of assisted reproductive technologies. Reproductive Medicine and Biology. 2014;13: 185-92.

[5]Kimura M, Matsushita T, Nakano M, Iwamoto T. Clinical analysis for factors predicting improvement of semen parameters following subinguinal microsurgical varicocele repair Journal of Fertilization and Implantation. 2014;31: 204-09.

[6]Kimura M, Shimura S, Tai T, et al. A Web-Based Survey of Erection Hardness Score and Its Relationship to Aging, Sexual Behavior, Confidence, and Risk Factors in Japan. Sex Med. 2013;1: 76-86.

[7]Kimura M, Banez LL, Polascik TJ, et al. Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction. Andrology. 2013;1: 256-61.

[8]Kimura M, Shimura S, Kobayashi H, et al. Profiling characteristics of men who use phosphodiesterase type 5 inhibitors based on obtaining patterns: data from the nationwide Japanese population. J Sex Med. 2012;9: 1649-58.

[9]Kimura M, Rabbani ZN, Zodda AR, et al. Role of oxidative stress in a rat model of radiation-induced erectile dysfunction. J Sex Med. 2012;9: 1535-49.

[10]Kimura M, Caso JR, Banez LL, et al. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy. BJU Int. 2012;110: E931-8.

[11]Kimura M, Banez LL, Gerber L, et al. Association between Preoperative Erectile Dysfunction and Prostate Cancer Features-An Analysis from the Duke Prostate Center Database. J Sex Med. 2012;9: 1174-81.

[12]Kimura M, Yan H, Rabbani Z, et al. Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model. J Sex Med. 2011;8: 2215-26.

[13]Kimura M, Donatucci CF, Tsivian M, et al. On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation. Int J Impot Res. 2011;23: 49-55.

[14]Kimura M, Banez LL, Schroeck FR, et al. Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy. J Sex Med. 2011;8: 2935-43.

[15]Kimura M, Rabbani Z, Mouraviev V, et al. Morphology of hypoxia following cryoablation in a prostate cancer murine model: its relationship to necrosis, apoptosis and, microvessel density. Cryobiology. 2010;61: 148-54.

[16]Kimura M, Rabbani Z, Mouraviev V, et al. Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study. Urology. 2010;76: 764 e14-20.

[17]Kimura M, Mouraviev V, Tsivian M, Moreira DM, Mayes JM, Polascik TJ. Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation. Urology. 2010;76: 1258-65.

[18]Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, Polascik TJ. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int. 2010;105: 191-201.

[19]Kimura M, Baba S, Polascik TJ. Minimally invasive surgery using ablative modalities for the localized renal mass. Int J Urol. 2010;17: 215-27.

[20]Kimura M, Tsivian M, Mouraviev V, et al. Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy. Int J Urol. 2009;16: 971-5.

[21]Kimura M, Satoh T, Okazaki M, et al. [Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy]. Nippon Hinyokika Gakkai Zasshi. 2008;99: 22-8.

[22]Kimura M, Onozawa M, Fujisaki A, et al. Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin. Int J Urol. 2008;15: 942-3.

[23]Kimura M, Irie A, Minei S, et al. [A case of adrenocortical adenoma coexisting with gastrointestinal stromal tumor]. Hinyokika Kiyo. 2007;53: 551-5.

[24] Kimura M, Satoh T, Fujita T, et al. [Cranial nerve palsies due to skull base metastases in patients with prostate cancer: a report of two cases]. Nippon Hinyokika Gakkai Zasshi. 2006;97: 748-51.

[25] Kimura M, Satoh T, Fujita T, et al. [Sudden death after 125I brachytherapy in prostate cancer patient: a case report]. Nippon Hinyokika Gakkai Zasshi. 2005;96: 560-3.